Japan generic drug maker Nichi-Iko to acquire Sagent of U.S.

Yuichi Tamura, president of generic drug company Nichi-Iko Pharmaceutical Co., has a press conference in Toyama, Japan, on July 11, 2016. Nichi-Iko will acquire U.S. generic drug maker Sagent Pharmaceuticals Inc. for roughly $736 million in a bid to expand its presence in the U.S. market. (Kyodo) ==Kyodo

Sample
PDF Preview

Product Code
ILEA000090185

Registered date
2016/7/11 19:49:27

Credit
Kyodo / Kyodo News Images

Media source
2016 Kyodo News

Media size
864 × 1118 pixel

Resolution
240 dpi

Deployment size
145.38(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

Konica Minolta to buy U.S. drug research company for 32 bil. yen

Konica Minolta Inc. President Shoei Yamana speaks at a press conference in Tokyo on Sept. 25, 2017. The Japanese maker of copiers, printers and precision equipment will acquire U.S. pharmaceutical research company Invicro LLC for roughly 32 billion yen ($284 million) in a bid to enhance its medical-related operations. (Kyodo) ==Kyodo

Chemical maker used Chinese drug ingredient without proper filing

Reporters gather in front of the headquarters of pharmaceutical chemicals maker Yamamoto Chemical Industry Co. in Wakayama, western Japan, on June 22, 2017. The company shipped an ingredient for common cold medication to drug companies after adding a Chinese-made component without the proper paperwork, according to health ministry officials. (Kyodo) ==Kyodo

Novartis Pharma unveils preventive measures against misconduct

Dirk Kosche, president of Novartis Pharma K.K., the Japanese unit of Swiss pharmaceutical maker Novartis AG, bows in apology during a press conference in Tokyo on June 9, 2015. Kosche unveiled measures to prevent the reoccurrence of company misconduct involving not reporting serious side effects of its drugs. (Kyodo) ==Kyodo